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Abstract. 
 
Cell death by apoptosis is a tightly regulated 
process that requires coordinated modification in cellu-
lar architecture. The caspase protease family has been 
shown to play a key role in apoptosis. Here we report 
that specific and ordered changes in the actin cytoskele-
ton take place during apoptosis.
In this context, we have dissected one of the first hall-
marks in cell death, represented by the severing of con-
tacts among neighboring cells. More specifically, we 
provide demonstration for the mechanism that could 
contribute to the disassembly of cytoskeletal organiza-
tion at cell–cell adhesion. In fact, 
 
b
 
-catenin, a known 
regulator of cell–cell adhesion, is proteolytically pro-
cessed in different cell types after induction of apopto-
sis. Caspase-3 (cpp32/apopain/yama) cleaves in vitro 
translated 
 
b
 
-catenin into a form which is similar in size 
to that observed in cells undergoing apoptosis. 
 
b
 
-Cate-
nin cleavage, during apoptosis in vivo and after 
caspase-3 treatment in vitro, removes the amino- and 
carboxy-terminal regions of the protein. The resulting 
 
b
 
-catenin product is unable to bind 
 
a
 
-catenin that is 
responsible for actin filament binding and organization. 
This evidence indicates that connection with actin fila-
ments organized at cell–cell contacts could be disman-
tled during apoptosis. Our observations suggest that 
caspases orchestrate the specific and sequential 
changes in the actin cytoskeleton occurring during cell 
death via cleavage of different regulators of the mi-
crofilament system.
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1. 
 
Abbreviations used in this paper
 
: aa, amino acid; Gas, growth arrest spe-
cific protein; ICE, interleukin-1
 
b
 
–convertase enzyme; MMS, methyl-
methanesulfonate.
 
A
 
poptosis 
 
is a fundamental cellular process in the de-
velopment and homeostasis of all multicellular or-
ganisms (Raff, 1992; Wyllie, 1995). Genetic analy-
sis in 
 
Caenorhabditis elegans
 
 has identified both positive
and negative regulators of apoptosis (Ellis et al., 1991).
The 
 
ced-3
 
 gene is essential for developmentally pro-
grammed cell death in 
 
C. elegans
 
: it encodes a protein
which shares homology with mammalian interleukin-
1
 
b
 
–convertase enzyme (ICE; Yuan et al., 1993).
ICE is a cystein protease that cleaves interleukin-1
 
b
 
 pre-
cursor at two aspartic residues and is activated by cleavage
after specific aspartic residues of a 45-kD proenzyme, thus
forming two subunits that together form the active site of
the enzyme (Thornberry et al., 1992). The regulatory mech-
anisms of the ICE remain to be clarified (Chinnaiyan et
al., 1997). In general, it exhibits full activity only after pro-
teolytic processing, which occurs either by self-cleavage or
through cleavage by other proteases (Nicholson, 1996).
Nine additional members of ICE-related proteases have
been identified in mammals (Fernandes-Alnemri et al.,
1994; Kumar et al., 1994; Wang et al., 1994; Faucheau et
al., 1995; Fernandes-Alnemri et al., 1995
 
a
 
,
 
b
 
; Boldin et al.,
1996; Duan et al., 1996
 
a
 
,
 
b
 
; Fernandes-Alnemri et al., 1996;
Muzio et al., 1996). Based on amino acid (aa)
 
1
 
 sequences
and recognized substrates, they have been grouped in dif-
ferent sub-families, and named according to the recently
proposed caspase nomenclature (Alnemri et al., 1996).
These proteases may overlap in their functions and/or reg-
ulate one another’s activities.
Indeed, recent observations suggest the existence of a
hierarchically ordered proteolytic cascade during apopto-
sis. In the case of CD95/FAS/APO-1-induced apoptosis,
an initial activity related to ICE itself (caspase-1), and a
later activity related to CPP32 (caspase-3), have been de-
scribed using specific inhibitor substrates (Enari et al.,
1996). Moreover, CD95/FAS/APO-1 receptors use the
adaptor molecule MORT1/FADD to physically engage a
cytosolic ICE-related cystein protease termed FLICE/
MACH (caspase-8) (Boldin et al., 1996; Muzio et al., 1996).
  
The Journal of Cell Biology, Volume 139, 1997 760
 
Caspase-8 might represent the most upstream protease in-
volved in generating a death signal.
The central role of the caspase proteases in mammalian
apoptosis is supported by the existence of specific inhibi-
tors. The viral proteins p35 and CrmA (Bump et al., 1995;
Xue and Horvitz, 1995), or aldehyde and fluormethylke-
tone derivatives of the target cleavage sequences, suppress
mammalian apoptosis as triggered by different stimuli
(Miura et al., 1993; Gagliardini et al., 1994; Beidler et al.,
1995; Nicholson et al., 1995).
If cystein proteases play a crucial role in apoptosis, spe-
cific target proteins or death substrates become critically
relevant for the execution phase of the apoptotic program.
Specific cleavage by ICE-related cystein proteases of
the DNA repair enzymes poly(ADP-ribose) polymerase
(PARP) and the catalytic subunit of the DNA-dependent
protein kinase (DNA-PK), is possibly related to the inacti-
vation of the DNA repair pathway as a choice of economy
(Lazebnik et al., 1994; Song et al., 1996). Cleavage of the
nuclear lamins is dependent on Mch2 (caspase-6) and
seems to be essential for disassembling the nuclear struc-
ture (Lazebnik et al., 1995; Takahashi et al., 1996). Other
substrates, whose function is still unclear during apoptosis,
are the 70-kD protein of the U1 small nuclear ribonucleo-
protein (Casciola-Rosen et al., 1994), the sterol regulatory
element-binding proteins SREBP-1 and SRBP-2 (Wang et
al., 1996), the huntingtin protein (Goldberg et al., 1996),
D4 GDP dissociation inhibitor (Na et al., 1996), and pRb
tumor suppressor (Janicke et al., 1996).
Two interesting substrates for caspases are the protein
kinase C
 
d
 
 and Gas2, the last being a component of the mi-
crofilament system (Brancolini et al., 1992). In both cases,
proteolytic processing results in a gain of function which
relates to increased kinase activity in the case of PKC
 
d
 
(Emoto et al., 1995), or to an activity on the microfilament
system and on cell morphology in the case of Gas2 (Bran-
colini et al., 1995). Recently, gain of function after caspase-3
processing has also been demonstrated for the p21-acti-
vated kinase 2 (Rudel and Bokoch, 1997), and the DNA
fragmentation factor (Liu et al., 1997).
Apoptotic morphological features are generally similar
in all systems where they have been studied: the nucleus
condenses and the cell shrinks and often fragments into
apoptotic bodies that are rapidly phagocytosed by neigh-
boring cells (Kerr et al., 1972; Wyllie et al., 1980).
The present study addresses the roles and changes of the
microfilament system during apoptosis. By a detailed con-
focal analysis on apoptotic NIH3T3 cells, we have identi-
fied specific sequential changes in the microfilament sys-
tem. Coordinately with actin filament reorganization in
the perinuclear area, the cell retracts from the adhesion
substrate and severs contacts with neighboring cells.
Germane to the above mentioned changes, we also ob-
served a specific modulation of the cell–cell contacts dur-
ing apoptosis through proteolytic processing of 
 
b
 
-catenin
thereby losing the ability to bind 
 
a
 
-catenin. Such proteolytic
cleavage in vitro is mediated by the cystein-protease cpp32/
apopain/yama (caspase-3).
In summary, the complex reorganization of cell mor-
phology during apoptosis seems to be achieved by specific
proteolytic processing of different regulators of actin cy-
toskeleton.
 
Materials and Methods
 
Cell Lines and Culture Conditions
 
NIH3T3 and MDCK cells were grown in DME supplemented with 10%
FCS, penicillin (100 U/ml), and streptomycin (100 
 
m
 
g/ml). In each experi-
ment 2.5 
 
3
 
 10
 
4
 
 cells/ml were seeded in 35-mm Petri dishes.
For serum starvation, medium was changed to 0.5% FCS when cells
were subconfluent and left in this medium for 48 h. For density-dependent
inhibition, cells were plated at 10
 
4
 
/cm
 
2
 
 in 10% FCS. 24 h after plating the
medium was changed every 2 d. For induction of apoptosis the culture me-
dium of arrested cells was replaced with serum-free DME. Nonadherent
and adherent cells were harvested, washed in serum-free medium, and sol-
ubilized in SDS-PAGE buffer. In the case of genotoxic-dependent apop-
tosis, density-inhibited cells were treated with 20 
 
m
 
g/ml of cisplatin for 4 h;
nonadherent and adherent cells were harvested separately 24 h later. For
UV treatment, culture medium was removed, dishes were washed once
with PBS, UVC irradiated (180 J/m
 
2
 
 in PBS), and fresh medium, contain-
ing 10% FCS, was added to the cells. Adherent and nonadherent cells
were harvested separately 24 h later. NIH3T3 cells were transfected as
previously described (Brancolini et al., 1995).
 
Plasmid Construction
 
Mouse 
 
b
 
-catenin cDNA (Hoschuetzky et al., 1994) was subcloned in-
frame with a COOH-terminal VSV tag (
 
b
 
-catenin–VSV) in pMT2SM-tag
(Bardelli et al., 1996) and pGDSV7S-tag (Brancolini et al., 1995). The 
 
b
 
-cate-
nin cDNA was amplified by PCR using a sense primer corresponding to
the T7 promoter (5
 
9
 
-AATACGACTCACTATAGGGC-3
 
9
 
) and a reverse
primer (VSV1) containing a SmaI site (5
 
9
 
-CCAAACTATGACTGGAG-
GGCCCATT-3
 
9
 
). The carboxy-terminal deleted derivative of 
 
b
 
-catenin
was produced by endonuclease digestion at the EcoRI site (nucleotides
1361/aa 421) and a COOH-terminal VSV tag was introduced by PCR using
a sense primer corresponding to the T7 promoter, and a reverse primer
(VSV2) containing a NotI site (5
 
9
 
-GATTGCGGCCGCAAGTGAGG-3
 
9
 
).
A site-directed mutagenesis method by overlap extension through PCR
as previously described (Brancolini et al., 1995) was used to produce the
point mutants D
 
®
 
A at different positions of the amino-terminal region of
 
b
 
-catenin. As external primers, the olT7 and olVSV2 were used. The pairs
of complementary inverse oligos were the following: 
 
b
 
-catenin 162–164D/A:
ol162–164u:5
 
9
 
-CTAAACGCTGAGGCCCAGGTGGTA-3
 
9
 
 ol162–164d:
5
 
9
 
-TACCACCTGGGCCTCAGCGTTTAG-3
 
9
 
; 
 
b
 
-catenin 144–145D/A:
ol144–145u:5
 
9
 
-TATCAGGCTGCCGCGGAACTT-3
 
9
 
 ol144–145d:5
 
9
 
-AAG-
TTCCGCGGCAGCCTGAT A-3
 
9
 
.
All constructs generated were sequenced using an automated (ALF)
system to check for the respective introduced mutations, deletions, and
translating fidelity of the inserted PCR fragments.
 
Immunofluorescence Microscopy
 
NIH3T3 cells were grown under the described conditions and then fixed
with 3% paraformaldehyde in PBS for 20 min at room temperature. Fixed
cells were washed with PBS/0.1 M glycine, pH 7.5, and then permeabilized
with 0.1% Triton-X100 in PBS for 5 min. The coverslips were treated with
the anti–
 
b
 
-catenin monoclonal antibody directed against aa 571–781 (Sig-
nal Transduction Laboratories, Lexington, KY) for 1 h in a moist chamber
at 37
 
8
 
C. TRITC anti–mouse (Southern Biotechnologies, Birmingham,
AL) was used as secondary antibody. Actin filaments were detected using
FITC-phalloidin (Sigma Chemical Co., St. Louis, MO) and nuclei were la-
beled with propidium iodide 5 mM (Sigma Chemical Co.).
Cells were examined with a laser scan microscope (LSM 410; Carl
Zeiss, Inc., Thornwood, NY) equipped with a 488 
 
l
 
 argon laser and a 543 I
helium neon laser. The following sets of filters were used: rhodamine
(BP546, FT580, and LP 590); and fluoresceine (450–490, FT 510, and
LP520).
 
Two-dimensional Gel Electrophoresis
 
NIH3T3 cells grown for 36 h in 0.5% FCS were labeled for 12 h in 1 ml of
DME methionine-free 0.5% FCS, containing 400 mCi/ml [
 
35
 
S]methionine
(Amersham Int’l., Little Chalfont, UK). Serum-free medium containing a
cold methionine chase, (0.5 mM final concentration) was then added for 6 h.
Samples of total cellular proteins were prepared from adherent and
nonadherent NIH3T3 cells after washing with cold PBS. Cells were lysed
in hot (100
 
8
 
C) lysis solution (0.3% SDS, 200 mM dithiothreitol, 50 mM 
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Tris-HCl, pH 8). Samples were then treated with 1:10 vol of nuclease solu-
tion (50 mM MgCl
 
2
 
, 50 mM Tris-HCl, pH 7, 1 mg/ml DNaseI, 0.25 mg/ml
RNaseA) for 10 min on ice, precipitated by adding ice-cold acetone to
80% vol/vol, and centrifuged at 14,000 
 
g
 
 for 10 min. Air-dried pellets were
resuspended in a mixture of 1 vol lysis solution and 4 vol of sample buffer
(9.9 M urea, 4% NP-40, 2.2% Millipore ampholytes, 100 mM dithiothrei-
tol). Two-dimensional gels were run using the investigator two-dimen-
sional electrophoresis system (Millipore Corp., Waters Chromatography,
Milford, MA) with pH 3–10 and pH 4–8 Millipore ampholytes in the first
dimension and 10% acrylamide in the second dimension.
 
Immunoblotting
 
For Western blotting, proteins were transferred to 0.2-
 
m
 
m pore-size nitro-
cellulose (Schleicher & Schuell Inc., Keene, NH) using a semidry blotting
apparatus (Bio-Rad Laboratories, Hercules, CA) (transfer buffer: 20%
methanol, 48 mM Tris, 39 mM glycine, and 0.0375% SDS). After staining
with Ponceau S, the nitrocellulose sheets were saturated for 2 h in Blotto-
Tween 20 (50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 5% nonfat dry milk,
and 0.1% Tween 20; Sigma Chemical Co.) and incubated overnight at
room temperature with a specific antibody: anti-Gas2, anti-actin, anti–
 
b
 
-cate-
nin and anti–
 
a
 
-catenin (Transduction Laboratories, Lexington, KY), anti–
 
b
 
-catenin amino-terminal (McCrea et al., 1993), anti–PKC-
 
d
 
 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), and anti-VSV (Sigma Chemical
Co.). Blots were then rinsed three times with Blotto-Tween 20 and re-
acted with peroxidase-conjugated goat anti–rabbit (Sigma Chemical Co.)
or goat anti–mouse (Sigma Chemical Co.) for 1 h at room temperature.
The blots were then washed four times in Blotto-Tween 20, rinsed in PBS,
and developed with an enhanced chemiluminescent kit, as recommended
by the vendor (Amersham Int’l.).
 
Expression of Caspase-3 (CPP32) in Bacteria and In 
Vitro Protease Assay
 
Caspase-3 cDNA was subcloned in-frame into the BamH1 site of the bac-
terial expression vector pQE-12 (QIAGEN Inc., Santa Clarita, CA). Cells
were grown to an A
 
600
 
 of 0.6 and expression of caspase-3 was induced by
adding isopropyl-
 
b
 
-
 
d
 
-thiogalactopyranoside to a final concentration of 1
mM. After 2 h, cells were collected by centrifugation at 3,000 
 
g
 
 for 5 min,
and then resuspended in 5 vol of caspase-3 buffer (Goldberg et al., 1996)
with protease inhibitors (1 mM PMSF and 10 
 
m
 
g/ml each aprotinin, leu-
peptin, and pepstatin). Cells were lysed by sonication and debris was sedi-
mented by centrifugation at 14,000 
 
g
 
 for 20 min. The resulting superna-
tants were used for in vitro protease assays.
Caspase-3 and 
 
b
 
-catenin were labeled with 
 
35
 
S using the TNT-coupled
reticulocyte lysate system (Promega Corp., Madison, WI). 1 
 
m
 
l of trans-
lated reticulocyte lysate was incubated with the appropiate dilution of the
bacterial lysates in caspase-3 buffer (final volume of 10 
 
m
 
l) for 1 h at 37
 
8
 
C.
Reactions were terminated by adding 1 vol of SDS gel loading buffer and
boiling for 3 min. The specific caspase-3/cpp32/apopain inhibitor Ac-Asp-
Glu-Val-Asp-CHO was obtained from Bachem Bioscience (Bubendorf,
Switzerland).
 
Immunoprecipitation
 
Analysis of 
 
b
 
-catenin–
 
a
 
-catenin complexes in apoptotic and nonapoptotic
cells was performed as previously described (Hulsken et al., 1994) with
some modifications. Cells were extracted with 140 mM NaCl, 4.7 mM KCl,
0.7 mM MgSO
 
4
 
, 1.2 CaCl
 
2
 
, 20 mM Tris-HCl, pH 7.5, 5% glycerol, contain-
ing 1% Triton X-100 and 1 mM PMSF, and 10 
 
m
 
g/ml each of aprotinin, leu-
peptin, antipain, and pepstatin. After centrifugation at 14,000 
 
g
 
 for 15 min
monoclonal antibodies, anti–
 
b
 
-catenin (Transduction Laboratories), or
anti-pan cadherin (Sigma Chemical Co.) were added. After 3 h on ice,
protein A–Sepharose (Pharmacia Biotech., Inc., Piscataway, NJ) was added
and incubation was prolonged for 1 h on ice. After a brief centrifugation
in Eppendorf centrifuge, immunoprecipitates were washed with 100 mM
NaCl, 5 mM EDTA, 20 mM Tris-HCl, pH 7.5, 1% Triton X-100 contain-
ing 1 mM PMSF, and 10 
 
m
 
g/ml each of aprotinin, leupeptin, antipain, and
pepstatin.
Immunocomplexes were released by boiling 5 min in SDS sample
buffer, separated in a 10% SDS-PAGE, and Western blots were per-
formed as described.
 
Results
 
Microfilament Reorganization during Apoptosis in 
NIH3T3 Cells
 
NIH3T3 fibroblasts efficiently organize stress fibers and
adhesion plaques and form cell–cell junctional complexes
and membrane ruffles. They represent an ideal system to
study microfilament organization in response to different
environmental conditions. Furthermore, growth-arrested
NIH3T3 cells readily respond to complete absence of se-
rum in the culture medium by undergoing apoptosis.
To study the changes in microfilament organization in
cells undergoing apoptosis, immunofluorescence analysis
was performed on growth-arrested NIH3T3 cells cultured
for a further 3 h in serum-free medium.
As shown in Fig. 1 
 
a
 
, after 3 h of incubation in serum-
free medium, changes in the microfilament organization
become clearly detectable in some cells as shown by phal-
Figure 1. Confocal analysis of the organization of actin in
NIH3T3 cells induced to enter apoptosis by deprivation of sur-
vival factors. Growth-arrested NIH3T3 cells were cultured for 4 h
in serum-free medium, fixed, and stained for actin filaments using
phalloidin-FITC (a), or double stained with propidium iodide, to
visualize nuclei (A, C, E, and G) and phalloidin-FITC (B, D, F,
and H). Bars: (a) 5 mm; (A–H) 1 mm. 
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loidin staining (
 
arrows
 
). As a response to the absence of
survival factors, cells apparently sever contacts with neigh-
boring cells, retract from the adhesion substrate, and dis-
mantle stress fibers, extensively reorganizing their actin
cytoskeleton.
Apoptosis is always accompanied by alterations in the
nuclear morphology, finally leading to nuclear fragmenta-
tion and formation of the apoptotic bodies. We, therefore,
decided to follow such nuclear alterations in relation to
the changes in actin organization during apoptosis.
When an initial alteration in nuclear architecture was
first detected (
 
arrow
 
, Fig. 1 
 
A
 
) changes in the actin cytoskel-
eton were also evident (Fig. 1 
 
B
 
). As described above, the
peculiar features at this stage included the severing of con-
tacts with neighboring cells, retraction of fibers, accumulation
of actin in the perinuclear region and loss of stress fibers.
At further stages, nuclear alterations become more evi-
dent leading to nuclear fragmentation (Fig. 1 
 
C
 
). At this
stage, the actin cytoskeleton is clearly organized in a ring-
like structure (Fig. 1 
 
D
 
, 
 
arrow
 
) with membrane blebbing
also clearly evident (data not shown). It is interesting to
note that nuclear fragments are external with respect to
the observed actin ring. This observation suggests that
contraction of actin filaments present in the perinuclear
region might be important in the sprouting of the nuclear
bodies. This hypothesis was supported by the most altered
phenotypes, showing the actin reorganization as summa-
rized in Fig. 1, 
 
E–H.
 
 At these stages the actin ring ap-
peared collapsed, with the nuclear fragments tending to
drop away from the actin filaments. This detachment
probably leads to the appearance of the phenotype repre-
sented in Fig. 1, 
 
G
 
 and 
 
H
 
, where only remnants of cyto-
plasm containing a collapsed actin ring structure were de-
tected. Such a phenotype could represent a final stage of
the microfilament changes taking place during apoptosis.
From this preliminary analysis, it could be appreciated
that apoptosis, as triggered by serum deprivation in NIH3T3
fibroblasts, is coupled to well-defined and ordered changes
of the microfilament system. Such changes are concomi-
tant with membrane blebbing and alteration of the nuclear
architecture.
 
Analysis of Actin Cleavage during Apoptosis in NIH3T3
 
Since it has been reported that actin can be cleaved in an
in vitro apoptotic system using purified caspase-1 (Mash-
ima et al., 1995; Kayalar et al., 1996), we analyzed as if in
vivo, during apoptosis, actin was cleaved in our defined
cellular system. In fact, this could possibly explain the dra-
matic reorganization of the microfilament system occur-
ring during cell death.
A time course analysis was performed on growth-arrested
NIH3T3 cells incubated in serum-free medium. Cell survival
was markedly decreased after few hours in serum-free me-
dium (Fig. 2 a) and apoptotic cells could be easily observed
floating in the medium (data not shown).
To study actin cleavage during apoptosis, both adherent
as well as nonadherent (floating dead cells) were com-
bined and Western analysis was performed.
As shown in Fig. 2 b, Gas2 was proteolytically processed
during apoptosis as previously reported (Brancolini et al.,
1995). Appearance of a band with increased mobility was
faintly detectable after 3 h from survival signal depriva-
tion. The intensity of the apoptotic band increased after 6 h,
concomitant with the accumulation of apoptotic cells in the
culture medium.
Under identical culture conditions, actin failed to show
any appreciable variation in size or expression levels as
observed in the different lanes (Fig. 2 b). As a further con-
trol, we analyzed the proteolytic cleavage of PKC-d, an-
other identified substrate of caspase proteases (Emoto et
al., 1995). PKC-d showed a similar kinetics of proteolysis
during apoptosis as previously described for Gas2 (Fig. 2 b).
Figure 2. (a) NIH3T3 cells grown for 48 h in 0.5% FCS were in-
cubated in serum-free medium for the indicated times (relative
numbers and percentages of viable cells were determined by try-
pan blue dye exclusion). Data represent arithmetic means 6 SD
for three independent experiments. (b) Growth-arrested NIH3T3
cells were incubated in serum-free medium for the indicated
times. Lysates from both adherent viable cells and nonadherent
apoptotic cells were combined and Western blot analysis was per-
formed. (c) Two-dimensional gel electrophoresis analysis show-
ing actin patterns in adherent and nonadherent apoptotic cells.Brancolini et al. Dismantling Cell–Cell Contacts during Apoptosis 763
The behavior of actins during apoptosis in vivo was also
analyzed by two-dimensional electrophoresis. NIH3T3
cells grown for 36 h in 0.5% FCS were labeled for 12 h
with [35S]methionine, and then simultaneously chased with
cold methionine and cultured in serum-free medium. Af-
ter 6 h, adherent and nonadherent cells were harvested
separately and two-dimensional gel electrophoresis was
performed as described in Materials and Methods. The
two-dimensional electrophoretic pattern of the different
actin isoforms (Garrels and Franza, 1989) did not show ap-
preciable differences between normal and apoptotic cells.
Interestingly, a new band, which might represent a post-
translational modification of an unknown product, became
detectable in the lysates from apoptotic cells (Fig. 3 C, ar-
rowhead). These results clearly demonstrate that during
apoptosis actin fails to be proteolytically processed, as trig-
gered by survival signal deprivation in NIH3T3 cells. In-
deed, resistance of actin to cleavage during apoptosis has
been recently reported (Song et al., 1997). Nevertheless,
we can not exclude that a minor fraction of actin is pro-
teolytically processed during apoptosis, or that this pro-
cessing does not occur in NIH3T3 cells.
Modulation of Cell–Cell Contacts during Apoptosis in 
NIH3T3 Fibroblasts
Having demonstrated that actin is not cleaved in vivo dur-
ing apoptosis in NIH3T3, we decided to search for other
regulators of the microfilament system that could be pro-
cessed during apoptosis and possibly involved in the dra-
matic reorganization occurring during cell death.
The previously reported analysis of microfilament changes
during apoptosis clearly suggested that a first hallmark of cell
death is the severing of contacts among neighboring cells.
Cell–cell contacts have been intensively studied in epi-
thelial cells, where specialized domains of the plasma
membrane and the adherens junctions play a critical role
in cellular adhesiveness by providing a link between cell
surface adhesion molecules and the cytoskeleton (Geiger
and Ayalon, 1992). Such an adhesive role is dependent on
members of the cadherin superfamily of adhesive recep-
tors and the cytoplasmic adaptor proteins a-, b-, and
g-catenin/plakoglobin, which connect the cadherins to the
actin filaments (for review see Gumbiner, 1996).
Fibroblasts in culture express functional cadherins (Itoh
et al., 1991), interact with one another, and assemble cad-
herins–catenin complexes (Knudsen et al., 1995).
To analyze the dynamics of cell–cell contacts during apop-
tosis in NIH3T3, as a first step we analyzed for the pres-
ence of cadherin–catenin complexes in this cell line. NIH3T3
cell lysates were immunoprecipitated using anti-pan cad-
herin antibody. After electrophoretic separation, the im-
munoblots were revealed with anti–a-catenin or –b-catenin
antibody. a-Catenin, b-catenin, and g-catenin/plakoglobin
were all detected in complexes with cadherin in NIH3T3
cells as previously demonstrated in other fibroblasts (data
not shown). As a next step we performed double immuno-
fluorescences to compare b-catenin distribution in relation
to actin cytoskeleton in apoptotic and nonapoptotic con-
fluent NIH3T3 cells. Intense staining for b-catenin was ob-
served at the cell–cell contacts in nonapoptotic NIH3T3
cells (Fig. 3, A and B). At an early apoptotic stage (Fig. 3
C, arrowhead), when a retraction response was observed,
b-catenin staining was rather diffuse, suggesting that disas-
sembly of cell–cell contacts occurred. However, some local-
ization at the cell–cell junction could still be detected, es-
pecially where the apoptotic cell still maintains contacts
with its neighbors (Fig. 3 D, arrows). In the more pro-
nounced apoptotic phenotype observed in Fig. 3 E (arrow-
head), b-catenin staining was mainly diffuse in the cyto-
plasm with no evidence for its presence at the cell border
(Fig. 3 F).
In summary, this analysis suggested that b-catenin local-
ization at the cell periphery was temporally and spatially
regulated during apoptosis in NIH3T3 cells.
Apoptosis Triggered by Both Survival Signal 
Deprivation and Genotoxic Stress Induces Proteolytic 
Cleavage of b-Catenin
We, therefore, asked whether the cell–cell adhesion dynamic
Figure 3. Confocal analysis of cell–cell contacts changes during
apoptosis in NIH3T3 cells. Apoptosis was induced by culturing
growth-arrested confluent NIH3T3 cells for 4 h in serum-free me-
dium. Confluent growth-arrested NIH3T3 cells (A and B) and
apoptotic NIH3T3 cells (C–F) were fixed and double stained for
actin filaments using phalloidin-FITC (A, C, and E) and for
b-catenin distribution (B, D, and E), using anti–mouse TRITC as
secondary antibody. Bar, 1.5 mm.The Journal of Cell Biology, Volume 139, 1997 764
could be regulated by proteolytic processing of the cytoso-
lic adaptor proteins during apoptosis. To test this hypothe-
sis, Western analysis of b-catenin on both adherent as well
as nonadherent (floating dead cells) NIH3T3 cells induced
to enter apoptosis following serum-free culture condition
was performed.
Deprivation of survival signals induced proteolytic cleav-
age of b-catenin giving rise to an z65-kD stable form clearly
evident at 6 h after treatment (Fig. 4 a).
The temporal pattern of such b-catenin processing was
closely related to the above described Gas2 and PKC-d apop-
totic processing. In fact, processing of b-catenin paralleled
the appearance of apoptotic cells in the culture medium
(data not shown).
Since b-catenin is known to associate with a-catenin, to
mediate the formation of cell–cell adhesion we also fol-
lowed a-catenin behavior during apoptosis. In this case
there was no evidence for proteolytic degradation of a-cate-
nin in NIH3T3 cells induced to enter apoptosis under the
same conditions (Fig. 4 a).
b-Catenin proteolytic processing was next analyzed us-
ing different apoptotic stimuli, such as genotoxic stress as
mediated by DNA-damaging agents. NIH3T3 cells were
treated with the chemotherapeutic agent cisplatin or irra-
diated with UV, and after 24 h adherent and nonadherent
(floating dead cells) were separately harvested. Western
blot analysis revealed that b-catenin was cleaved to a z65-kD
form exclusively in the apoptotic cells and, on the con-
trary,  a-catenin failed to be processed under the same con-
ditions (Fig. 4 b).
Adherens junctions are found in many cell types, includ-
ing cardiac myocytes and fibroblasts, but they have been
extensively studied in epithelial cells. Therefore, we simi-
larly investigated proteolytic processing of b-catenin dur-
ing apoptosis in MDCK cells. Apoptosis was induced by
both serum deprivation and DNA damage using increas-
ing amounts of the alkylating agent methylmethanesul-
fonate (MMS). Western analysis was performed on adherent
and nonadherent cells harvested separately, in the case of
serum starvation, or jointly, in the case of MMS treatment.
Proteolytic processing of b-catenin in MDCK cells was
detected when apoptosis was induced either by serum star-
vation (Fig. 4 c) or by DNA damage (Fig. 4 d). In the last
instance, the relative amount of the processed form paral-
leled the increased level of genotoxic insult and the ap-
pearance of apoptotic cells in the culture medium (data
not shown). Here again, both a-catenin and actin failed to
be processed.
Since it has been demonstrated that Bcl-2 oncoprotein
prevents/delays apoptosis and inhibits activation of the
caspase proteases (Shimizu et al., 1996; Chinnaiyan et al.,
1997), we investigated the fate of b-catenin during apop-
totic stimuli in the presence of increased Bcl-2 expression.
When NIH3T3 overexpressing Bcl-2 were analysed for
proteolytic processing of b-catenin under serum-free con-
ditions, apoptosis and proteolytic cleavage of Gas2 and
b-catenin were dramatically suppressed (Fig. 5).
b-Catenin cleavage during apoptosis was also observed
in the presence of the proteosome inhibitor N-acetyl-leuci-
nyl-leucinyl-norleucinal-H, an inhibitor of the chymotryp-
tic site on the proteosome (Pagano et al., 1995), thus sug-
gesting that it is not mediated by the ubiquitin/proteosome
system (data not shown).
We can, therefore, conclude that proteolytic cleavage of
b-catenin correlates with activation of a cell death pro-
gram in both fibroblast and epithelial cells, all the b-cate-
nin pool is cleaved during apoptosis and this processing is
suppressed by increased expression of Bcl-2.
b-Catenin Is Cleaved by Caspase-3 In Vitro
We next asked whether enzymes of the caspase family
could be responsible for the proteolytic cleavage of b-cate-
nin during apoptosis. We analyzed whether caspase-3, one
of the late-activated proteases in the apoptotic proteolytic
cascade, was able to cleave b-catenin in vitro.
Full-length b-catenin cDNA was translated in vitro and
Figure 4. Analysis of b-catenin cleavage during apoptosis in
NIH3T3 and MDCK cells. (a) Growth-arrested NIH3T3 cells
were incubated in serum-free medium for the indicated times.
Lysates from both adherent viable cells and nonadherent apop-
totic cells were combined and Western blot analysis was per-
formed. (b) Density-arrested NIH3T3 cells were treated with 20
mg/ml of cisplatin or UV irradiated as described in Materials and
Methods. After 24 h adherent (A) and nonadherent (NA) cells
were processed separately and Western analysis was performed.
(c) MDCK cells grown for 4 d in 10% FCS were incubated in se-
rum-free medium for 12 h. Adherent (A) and nonadherent (NA)
cells were processed separately and Western analysis was per-
formed. (d) MDCK cells grown for 4 d in 10% FCS were treated
for 4 h with the indicated amount of MMS. After 24 h, lysates
from both adherent viable cells and nonadherent apoptotic cells
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treated with caspase-3 from a bacterial lysate (Fernandes-
Alnemri et al., 1995b; Song et al., 1996; Xue et al., 1996).
Treatment with caspase-3 specifically cleaved b-catenin,
producing a fragment of z65 kD, whereas lysates from
bacteria not expressing caspase-3, grown and extracted un-
der identical conditions, failed to cleave b-catenin (Fig. 6
a). Moreover, caspase-3–dependent proteolytic cleavage
of  b-catenin could be prevented by addition of the specific
caspase inhibitor, the acidic tetrapeptide aldehyde Ac-
DEVD-CHO (Fig. 6 b). It is worth noting that when Ac-
DEVD-CHO was used at a final concentration of 20 nM,
only a partial inhibition of the b-catenin cleavage oc-
curred, and in parallel an intermediate proteolytic product
was detected.
Having demonstrated that caspase-3 cleaves b-catenin,
we tried to define whether b-catenin is a relevant substrate
for this protease. Caspase-3, like other proteases of this
family, can undergo autocatalytic cleavage, thus producing
an intermediate form (p21) and two active forms, p17 and
p12 (Fernandes-Alnemri et al., 1995b; Nicholson et al.,
1995; Martin et al., 1996; Wang et al., 1996; Xue et al., 1996).
Caspase-3 autoprocessing can be easily monitored by
following the disappearance of the p32 precursor form us-
ing an in vitro protease assay (Fernandes-Alnemri et al.,
1995b; Martin et al., 1996; Wang et al., 1996; Xue et al.,
1996). In vitro translated caspase-3 was incubated with in-
creasing amounts of bacterial lysates expressing active
caspase-3 and compared to the efficiency of b-catenin
cleavage over the same time course.
The same caspase-3 activity that is responsible for full
b-catenin processing could only partially self-cleave the in
vitro translated caspase-3 precursor form (Fig. 6 c). In fact,
12 mg, the equivalent of total proteins from bacterial ex-
Figure 5. (A) NIH3T3-NEO or NIH3T3 cell lines transfected
with  bcl-2 were grown for 48 h in 0.5% FCS and incubated in se-
rum-free medium (relative numbers and percentages of viable
cells were determined by trypan blue dye exclusion). Data repre-
sent arithmetic means 6 SD for three independent experiments.
(B) Growth-arrested NIH3T3-NEO and NIH3T3–bcl-2 cells
were incubated in serum-free medium for the indicated times.
Lysates from both adherent viable cells and nonadherent apop-
totic cells were combined and Western blot analysis was per-
formed.
Figure 6. In vitro protease assays. (a) 35S labeled in vitro trans-
lated b-catenin was incubated for 1 h at 378C with caspase-3
buffer alone or with the indicated amounts of caspase-3–express-
ing bacteria lysates or control bacteria lysates. (b) 35S labeled in
vitro translated b-catenin was incubated for 1 h at 378C with
caspase-3 buffer alone, with control bacteria lysates, with
caspase-3–expressing bacteria lysates, or in the presence of the in-
dicated amount of caspase-3–specific inhibitor Ac-DEVD-CHO.
(c) 35S labeled in vitro translated caspase-3 precursor was incu-
bated for 1 h at 378C with caspase-3 buffer alone, or with the indi-
cated amount of caspase-3–expressing bacterial lysates or control
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tracts expressing caspase-3, were required for full process-
ing of caspase-3 precursor with respect to the 2 mg suffi-
cient for full b-catenin processing. Caspase-3–dependent
processing specificity of b-catenin is also strengthened by
the observation that an amount of caspase-2 (ICH-1),
enough for full autoprocessing, was unable to cleave b-cate-
nin in vitro (data not shown).
In summary, these data indicate that b-catenin is a bet-
ter substrate for caspase-3 than itself, thus strongly sug-
gesting that b-catenin is a relevant caspase-3 substrate.
b-Catenin Is Cleaved at Different Sites by Caspase-3
Experiments using the caspase-3 inhibitor Ac-DEVD-CHO
suggested that b-catenin could be cleaved at different sites.
To study the overall pattern of b-catenin processing, we
performed a time course analysis of b-catenin processing
in vitro using bacterial lysates expressing caspase-3. In vitro
translated b-catenin was incubated for the indicated times
at 378C with caspase-3–expressing or control bacterial ly-
sates.
After 2.5 min of incubation, partial proteolytic process-
ing of b-catenin could be detected (Fig. 7 a). A major
cleavage product of z90 kD, in addition to the common
but minor z65-kD form, was, in fact, revealed at this time.
After a 10-min incubation, only the z65-kD form was
present, thus suggesting that the z90-kD form could rep-
resent an intermediate degradation product of b-catenin.
This result, however, suggested that caspase-3 has greater
affinity for full-length b-catenin to generate the z90 kD
than for the full-length or the z90 kD to generate the
z65-kD form. Incubation with control bacterial lysates did
not induce such proteolytic processing.
As a first step to identify the sites of b-catenin that are
cleaved by caspase-3, we constructed a tagged b-catenin
with the in-frame VSV epitope at its carboxy terminus.
In vitro translated b-catenin–VSV was incubated for 2.5
or 60 min at 378C with caspase-3-expressing or control
bacterial lysates and then Western blot was performed us-
ing antibodies against b-catenin or VSV.
After 2.5 min of incubation with caspase-3, a prominent
z90-kD form and a minor z65-kD band were revealed by
antibodies against b-catenin. After 60 min of incubation,
only the z65-kD form was detectable (Fig. 7 b).
Since antibodies against VSV failed to detect both the
z90- and z65-kD cleaved forms of b-catenin, we can sug-
gest that the carboxy tail is the first one to be proteolyti-
cally attacked by caspase-3.
Moreover, comparison between b-catenin in extracts
from MDCK cells undergoing apoptosis revealed a similar
electrophoretic mobility with respect to the in vitro,
caspase-3 processed, z65-kD form of b-catenin.
From this analysis we can conclude that b-catenin, as
synthesized in vitro, is cleaved by caspase-3 at at least two
different sites generating the final z65-kD form that
closely resembles the processed form previously identified
in vivo during apoptosis.
To explain the observed processing dynamics, we can
hypothesize an initial caspase-3–dependent cleavage event
that removes a fragment of z2 kD located at the carboxy-
terminal of b-catenin.
Cleavage of b-Catenin during Apoptosis Abolishes Its 
Ability to Bind a-Catenin
We next assessed whether b-catenin was cleaved at the
carboxy-terminal domain during apoptosis in vivo. NIH3T3
were transfected with the b-catenin–VSV construct, apop-
tosis was induced by serum deprivation, and adherent and
nonadherent cells were harvested separately for Western
analysis.
The apoptotic cleaved form of b-catenin (65 kD) was
detected in apoptotic cells (nonadherent) using the anti-
body specific for aa 571–781, but it was undetectable using
antibodies against the VSV tag (Fig. 8 a). To exclude the
possibility that during apoptosis the VSV tag was cleaved
instead of the b-catenin carboxy-terminal region, we trans-
fected the cytoplasmic adenylate kinase containing the
VSV tag at its carboxy-terminus as a control. Apoptosis
was similarly induced by serum deprivation, and nonad-
herent cells were harvested separately for Western analy-
sis. Adenylate kinase VSV was similarly detected in both
apoptotic and nonapoptotic cells (Fig. 8 a). These results
indicate that the carboxy terminal domain of b-catenin is
specifically processed during apoptosis at a site further up-
stream of the tag in vivo.
To analyze whether the amino-terminal region of b-cate-
nin was also cleaved during apoptosis in vivo, we used an
antibody against the amino-terminal region of b-catenin
Figure 7. (a) 35S labeled in vitro translated b-catenin was incu-
bated for 1 h at 378C with caspase-3 buffer (lane B), or with 2 mg
of caspase-3–expressing bacterial lysates or control bacterial ly-
sates for the indicated times. (b) Western immunoblots were per-
formed on in vitro translated b-catenin and cellular lysates from
(A) adherent nonapoptotic, and (NA) nonadherent apoptotic
MDCK cells using antibodies against b-catenin or against VSV-
tag. In vitro translated b-catenin was incubated for 1 h at 378C
with caspase-3 buffer (lane B) or with 2 mg of caspase-3–express-
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(aa 6–138) (McCrea et al., 1993). Apoptosis was induced in
NIH3T3 cells by serum deprivation and in MDCK by
MMS treatment, and adherent and nonadherent cells were
harvested separately for Western analysis.
As shown in Fig. 8 b, antibodies specific for the amino-
terminal region recognize b-catenin only in nonapoptotic
cells, thus indicating that the amino-terminal region of
b-catenin is also proteolytically cleaved both in MDCK
and NIH3T3 apoptotic cells.
Since the amino-terminal region of b-catenin is critically
involved in binding a-catenin, we decided to analyze whether,
during apoptosis, b-catenin was able to maintain the com-
plex with a-catenin or, due to proteolytic cleavage at the
amino-terminal, such a complex was compromised.
Apoptosis was induced in both NIH3T3 and MDCK cells
by serum deprivation, and nonapoptotic and apoptotic
floating cells were harvested separately. The same amount
of proteins derived from apoptotic and nonapoptotic cell
lysates were immunoprecipitated using anti–b-catenin anti-
body. After electrophoretic separation, the immunoblots
were revealed with anti–a-catenin antibody.
Fig. 8 c shows that the same amount of a-catenin could
be detected in the lysates of apoptotic and nonapoptotic
cells used for immunoprecipitation. However, a-catenin
was not found in complexes with the apoptotic form of
b-catenin, whereas it was detected in complexes with
b-catenin in the viable cells.
The same blots were also analyzed with antibodies against
b-catenin to demonstrate that the two different forms of
b-catenin were similarly immunoprecipitated under the
different experimental conditions (Fig. 8 c).
These results clearly demonstrate that the proteolytic
processing at the amino-terminal of b-catenin during apop-
tosis is the major determinant for the loss of interaction
with a-catenin, which should, therefore, contribute to dis-
mantling actin anchorage from the cell adhesion receptors.
Caspase-3–Dependent Proteolytic Processing of the 
Amino-Terminal Region of b-Catenin
To further confirm that the amino-terminal region of b-cate-
nin was cleaved during apoptosis by a caspase, a deleted
carboxy-terminal version of b-catenin (b-cateninDCT),
missing aa 422–781 was produced, and a VSV tag was in-
troduced at the carboxy-terminal. Digestion of the in vitro
translated b-cateninDCT with caspase-3 produced a major
band of z32 kD, which was completely suppressed by ad-
dition of the specific inhibitor Ac-DEVD-CHO (Fig. 9 a).
Using decreasing amounts of caspase-3, a complex pattern
of digestion products was observed, probably representing
partial proteolytic products (Fig. 9 a). This evidence sug-
gests the existence of multiple target sites for caspase pro-
teases within the amino-terminal region of b-catenin.
As a first attempt to map the amino-terminal cleavage
sites and to further confirm that caspase-3 cleaves the
amino-terminal domain of b-catenin, we decided to per-
form a mutagenesis analysis. Different mutants of the
b-catenin amino-terminal region were constructed by in-
troducing point mutations that substitute the aspartic resi-
due with alanine within the amino-terminal region. More
specifically, the double-point mutants b-cateninDCT144–
145D/A and b-cateninDCT162–164D/A were created, and
the resulting constructs were in vitro transcribed/trans-
lated. The in vitro translated products were then incubated
Figure 8. (a) NIH3T3 cells transfected
with  b-catenin–VSV or with adenylate ki-
nase were incubated in serum-free me-
dium for 12 h. Adherent (A) and nonad-
herent (NA) cells were processed
separately and Western analysis was per-
formed using anti–b-catenin (aa 571–781)
or anti–VSV-tag antibodies. (b) Growth-
arrested NIH3T3 cells were incubated in
serum-free medium for 12 h. Adherent
(A) and nonadherent (NA) cells were pro-
cessed separately and Western analysis
was performed using anti–b-catenin (aa
571–781), or anti–amino-terminal b-cate-
nin (aa 6–138) (McCrea et al., 1993). (c)
NIH3T3 and MDCK cells were incubated
for 12 h in serum-free medium. Adherent
(A) and nonadherent (NA) cells were pro-
cessed separately. Immunoprecipitation
using anti–b-catenin was performed as de-
scribed in Materials and Methods. The im-
munocomplexes were resolved in SDS-
PAGE and processed for Western blot
analysis with anti–a-catenin or anti–b-cate-
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with caspase-3–expressing bacterial lysates and immuno-
precipitated using the antibody against the VSV tag.
As predicted by the existence of multiple cleavage sites,
the different point mutants tested were cleaved by cas-
pase-3, and Ac-DEVD-CHO completely abolished this
processing (Fig. 9 b). The cleaved products were efficiently
immunoprecipitated with the anti-VSV antibody, thus in-
dicating that the multiple cleavage sites of b-cateninDCT
lie in the amino-terminal part of the protein (Fig. 9 b).
Most interestingly, different electrophoretic shifts were
observed, distinguishing the proteolytic products of the
double mutants 144–145D/A and 162–164D/A from the
one generated from the wtb-cateninDCT (Fig. 9 b).
The small electrophoretic shift of the digested b-cate-
ninDCT162–164D/A suggests that at least one or both of
the two aspartic residues represent cleavage sites for
caspase-3. Since caspase-3 digestion of b-cateninDCT144–
145D/A double mutants produced a larger electrophoretic
shift, we can infer that the mutated 144–145 aspartic resi-
dues could represent caspase-3 cleavage sites.
A possible explanation for the described proteolytic pat-
tern is that in vitro cleavage at residues 162 and/or 164 re-
quires previous cleavage at position 144 and/or 145. Sub-
stitution of aspartic residues 144 and/or 145 should also
interfere with proteolytic processing at position 162–164,
thus leading to an incomplete digestion product with a
more evident reduced electrophoretic mobility.
In summary, these results demonstrate that within the
amino-terminal domain of b-catenin, different aspartic
residues are targets for caspase-3 cleavage. More specifi-
cally, aspartic residues at position 162 and/or 164 and 144
and/or 145 of b-catenin serve as caspase-3 targets within
the amino-terminal region.
Discussion
It is becoming evident that the caspase family of cellular
proteases plays an important role in the execution phase
of apoptosis (Kumar, 1995; Fraser and Evan, 1996; Nichol-
son, 1996). The activity of a protease results in the cleav-
age of various substrates. Some specific substrates for
caspase proteases have been identified and in some cases a
relationship with the apoptotic process could be clarified
(Casciola-Rosen et al., 1994; Lazebnik et al., 1994; Bran-
colini et al., 1995; Emoto et al., 1995; Lazebnik et al., 1995;
Goldberg et al., 1996; Janicke et al., 1996; Na et al., 1996;
Song et al., 1996; Wang et al., 1996; Liu et al., 1997; Rutel
and Bokoch, 1997). However, further identification of crit-
ical substrates for caspase proteases is fundamental to un-
veil the execution phase of apoptosis.
In this report we show that when apoptosis was induced
either by complete growth factor removal or genotoxic
stress, b-catenin becomes efficiently cleaved to produce a
stable z65-kD form in both epithelial and fibroblast cells.
b-Catenin is a z92-kD protein component of cell–cell con-
tacts and adherens junctions having both structural and
signaling functions (Miller and Moon, 1996). The reported
cleavage of b-catenin seems to be (a) specific, since a-cate-
nin, another component of adherens junctions, is not ap-
parently processed during apoptosis, (b) coupled to the
onset of apoptosis, since it was coincident with Gas2 acti-
vation, and (c) suppressed by the antiapoptotic protein
Bcl-2 and proportional to the level of apoptotic insult.
The cleavage product generated after in vitro treatment
of translated b-catenin protein with active caspase-3 (cpp32/
apopain/yama) migrates with the same apparent size as
the b-catenin cleavage product of apoptotic MDCK cells,
supporting the idea that in vivo such cleavage is also medi-
ated by a caspase protease. Kinetics studies in vitro and
functional studies in vivo indicate that b-catenin is cleaved
at different sites, thus trimming both the amino- and car-
boxy-terminal regions of the protein.
The caspase family of proteases contains a QACXG
pentapeptide in which the cysteine participates in catalysis
and is characterized by the absolute requirement for an as-
partic acid residue in the substrate P1 position (Thorn-
berry et al., 1992). In addition to the requirement for a P1
Asp, caspase-3 shows preference for an anionic Asp resi-
due in the P4 residue (DXXD) (Nicholson, 1996). A
DXXD consensus site is located in the carboxy-terminal
part of b-catenin (aa 760–764: DLMDG), thus possibly ex-
plaining the rapid cleavage of the carboxy-terminal site of
the protein as observed in vitro after incubation with
caspase-3. This sequence is similar to the DQMDG site in
p35, a baculovirus antiapoptotic protein that is efficiently
cleaved by caspase-3 (Xue and Horvitz, 1995).
We have demonstrated that aspartic residues 144 and/or
145, 162 and/or 164 are target sites for caspase-3 cleavage
in vitro and that upstream, different aspartic residues
Figure 9. (a) 35S labeled in vitro translated b-cateninDCT was in-
cubated for 1 h at 378C with control bacterial lysates or with in-
creasing amount of caspase-3–expressing bacterial lysates. (b) 35S
labeled in vitro translated b-cateninDCTwtVSV, b-cateninD-
CT162–164D/AVSV, and the b-cateninDCT144–145D/AVSV
were incubated with caspase-3–expressing bacterial lysates or
with caspase-3–expressing bacterial lysates in the presence of 200
nM Ac-DEVD-CHO. Immunoprecipitations were performed us-
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within the amino-terminal region of b-catenin are also
cleaved by caspase-3, none of them showing a canonical
DXXD sequence. These observations raised the question
whether caspase-3 is the protease involved in processing of
the amino-terminal domain in vivo, or other caspases show
higher affinity for such amino-terminal sites. Indeed, the
recent generation of caspase-3 null mice (Kuida et al.,
1996), clearly demonstrates that caspase-3 play a critical
role during morphogenetic cell death in the mammalian
brain but raises the possibility that other caspase proteases
may have an important role during apoptosis in other tis-
sues or in response to cell death-trigger.
Therefore, we can hypothesize that b-catenin could also
be a target for other caspases; further studies are required
to understand if other caspases are involved in b-catenin
processing, and to identify the different aspartic residues
cleaved during apoptosis.
Adherens junctions link cells together by organizing ac-
tin filaments to the plasmamembrane. The transmem-
brane receptors are the cadherins, a family of homophilic
Ca21-dependent cell–cell adhesion molecules (Takeichi,
1995). Their crystal structures suggest that cadherin-medi-
ated cell adhesion is not based solely on the stability of as-
sociation among individual molecules, but rather by the
generation of a cell adhesion zipper which provides a
mechanism to form strong intercellular bonds (Shapiro et
al., 1995). In vivo strong intercellular bonds are dependent
upon the association of the cadherin carboxy-terminal cy-
toplasmic domain to the central region of b-catenin and
g-catenin/plakoglobin (Nagafuchi and Takeichi, 1988; Ozawa
et al., 1989; Hulsken et al., 1995; Sacco et al., 1995). Dele-
tion of the b-catenin–binding site from cadherin cytoplasmic
domain renders the cadherin nonfunctional in a cell aggre-
gation assay (Nagafuchi and Takeichi, 1988; Ozawa et al.,
1989).
The central function of b-catenin as a regulator of adher-
ens junctions has been further demonstrated in different
organisms using different experimental approaches (Peifer
et al., 1993; Oyama et al., 1994; Haegel et al., 1995). It has
been extensively demonstrated that b-catenin serves as an
adapter to link cadherins to a-catenin and thereby to the
actin cytoskeleton, since a-catenin seems to interact with
both actin and a-actinin (Knudsen et al., 1995; Rimm et
al., 1995). In this context, b-catenin seems to be the critical
component for cadherin–catenin complexes in the regula-
tion of cellular adhesiveness (Hamaguchi et al., 1993;
Cowin and Bruke, 1996).
The fundamental roles of a-catenin in cadherin cyto-
skeleton interactions have also been clearly established in
various cell types. Nonadhesive epithelial tumor cells lack-
ing a-catenin can be induced to form tightly adherent epi-
thelia after reintroduction of a-catenin (Watabe et al.,
1994). Moreover, expression of E-cadherin–a-catenin chi-
meras has been reported to induce a strong and inflexible
adhesive phenotype (Nagafuchi et al., 1994).
We have demonstrated in vivo that proteolytic process-
ing of the b-catenin at its amino-terminal domain impairs
its ability to bind a-catenin. Amino acid residues 120–151
of b-catenin, embedded in the amino-terminal domain and
containing the first ARM repeat, are required for interac-
tion with a-catenin (Aberle et al., 1994). This is confirmed
in the human gastric cell line HSC-39 where a truncated
b-catenin originated from a homozygous in-frame deletion
that removes aa 28–134, cannot interact with a-catenin
(Oyama et al., 1994; Kawanishi et al., 1995). The observa-
tions that: (a) an antibody raised against aa 6–138 (Mc-
Crea et al., 1993) of the amino-terminal region of b-cate-
nin fails to detect the apoptotic form of b-catenin, and (b)
aspartic residues 144 and/or 145, 162 and/or 164 are targets
for caspase-3 cleavage in vitro, further confirming that
proteolytic processing of b-catenin during apoptosis im-
pairs interaction with a-catenin. Removal of the b-catenin
domain responsible for interaction with a-catenin should
contribute to disassemble the connections among the ad-
hesion receptors, cadherins, and the actin cytoskeleton,
thereby impairing a sustained cell–cell adhesive interac-
tion (Fig. 10). An early marker of apoptosis in confluent
cells is the retraction from neighboring cells, which is
probably coincident with disassembly of cell–cell contacts.
This process seems to be both temporally and spatially
regulated and probably not exclusively dependent on b-cate-
nin cleavage. In fact, b-catenin–related member, g-cate-
nin/plakoglobin, also plays a similar role in regulating cad-
herin adhesive activity in adherens junctions and in the
specialized desmosomal junctions. The aspartic residues
144 and/or 145 and 162 and/or 164 possible target sites for
caspase activity in b-catenin, are conserved among b-catenin,
g-catenin, and armadillo (the Drosophila form of b-cate-
nin). Indeed, we also noticed that g-catenin/plakoglobin
was proteolytically processed both in vitro after incubation
with caspase-3, and in vivo during apoptosis in fibroblast
and epithelial cells (Brancolini, C., manuscript in preparation).
Figure 10. Schematic representation of b-catenin cleavage during
apoptosis. Apoptotic stimuli lead to activation of the caspase pro-
teases, removing both a segment of b-catenin from the carboxy-
terminal domain and from the amino-terminal domain including
the first armadillo repeat (black arrows). Cleaved b-catenin is re-
leased from a-catenin, thereby losing the connections to the cy-
toskeleton. Unmapped caspase cleavage sites are indicated by
hatched arrows.The Journal of Cell Biology, Volume 139, 1997 770
It is interesting to note that E-cadherin complexes may
promote cell survival and suppress cell death in epithelial
cells (Hermiston and Gordon, 1995). In this context, cleav-
age of b-catenin might also suppress transduction of sur-
vival signals, consequently contributing to the one-way
proceeding of the apoptotic process. The evidence that
some components of microfilament system are substrates
for the caspase proteases (Brancolini et al., 1995; Martin et
al., 1996; Na et al., 1996), suggests that these proteases co-
ordinate actin architectural changes during apoptosis and
that such changes are important for a normal apoptotic
phenotype (Cotter et al., 1992).
In conclusion, a complex reorganization of the microfil-
ament system was observed during cell death: cells retract
from adhesion substrate, sever the contacts with neigh-
bors, and actin filaments are concentrated in the perinu-
clear area in a ring-like organization. Collapsing of the
ring-like structure becomes evident with the proceeding of
the morphological changes accompanied by nuclear frag-
mentation, membrane blebbing, and formation of the apop-
totic bodies.
In this context, b-catenin and Gas2 processing seem to
have different roles. Cleavage of Gas2 seems to be impor-
tant to switch on the ability to rearrange the microfilament
system, which may be relevant for the organization of the
ring-like structure (Brancolini et al., 1995). Cleavage of
b-catenin seems to be responsible for switching off its
function as a regulator of adherens junctions, and is possibly
instrumental for severing contacts with neighboring cells.
b-Catenin is also found in the nucleus and cytoplasm,
where its function is not restricted to modulation of adher-
ens junctions. Association of b-catenin with the tumor-
suppressor gene product APC (adenomatous polyposis co-
lon) (Rubinfeld et al., 1993) and the transcription factors
LEF-1/XTcf-3 (Behrens et al., 1996; Molenaar et al., 1996)
have, in fact, been reported. Moreover, b-catenin, to-
gether with the related protein g-catenin/plakoglobin and
Armadillo, is implicated in the Wnt/wingless signaling
pathway, which determines the dorsoventral axis in Xeno-
pus and segment polarity in Drosophila (for review see
Miller and Moon, 1996).
To unveil the relationships among the specific roles of
b-catenin in the regulation of cell growth/differentiation
and its proteolytic processing during apoptosis will be an
exciting challenge for the future.
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